|
|
 |
|
Viewing report
|
|
|
|
Analgesics Market in the Netherlands to 2014 (OTC Healthcare)
Datamonitor, Feb 2011, Pages: 27
Introduction
This databook provides key data and information on the Analgesics Market in the Netherlands (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
The analgesics category was valued at €125.2m ($183.3m) in 2009, representing a CAGR of 2.8% since 2004.
By the end of 2014, the analgesics category will be worth €125.8m ($184.2m), with an expected CAGR of 0.1% between 2009 and 2014.
The analgesics market was led by paracetamol (representing 49% of the total value) followed by aspirin and other analgesics, with a 27.6% and 18.2% market share, respectively. Ibuprofen accounts for the remaining 5.2% share.
Bional Pharma B.V. is the market leader with a 24.9% share of the market.
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Analgesics Market in the Netherlands (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
|
|
|
|
